tiprankstipranks
Green Future Food Hydrocolloid Marine Science Co., Ltd. (HK:1084)
:1084
Hong Kong Market
Want to see HK:1084 full AI Analyst Report?

Green Future Food Hydrocolloid Marine Science Co., Ltd. (1084) AI Stock Analysis

0 Followers

Top Page

HK:1084

Green Future Food Hydrocolloid Marine Science Co., Ltd.

(1084)

Select Model
Select Model
Select Model
Neutral 43 (OpenAI - 5.2)
Rating:43Neutral
Price Target:
HK$0.64
▲(2.74% Upside)
Action:ReiteratedDate:04/29/26
The score is held down primarily by deteriorating profitability and a sharp reversal to negative operating/free cash flow in 2025, despite revenue growth and manageable leverage. Technical indicators are broadly neutral with slightly negative momentum, and valuation is a notable headwind due to the very high P/E and only modest dividend yield.
Positive Factors
Revenue rebound
A 21.3% revenue rebound in 2025 signals recovering end-market demand and sales momentum that can support durable capacity utilization and margin recovery. Sustained top-line growth provides a foundation to rebuild profitability and cash generation if cost structure and pricing are managed.
Negative Factors
Profitability deterioration
Net margin compression to ~0.7% and a steep drop in net income indicate structural profit pressure from lower gross margins or higher operating costs. Persistently thin margins reduce reinvestment ability, heighten sensitivity to cost shocks, and make earnings less durable over the medium term.
Read all positive and negative factors
Positive Factors
Negative Factors
Revenue rebound
A 21.3% revenue rebound in 2025 signals recovering end-market demand and sales momentum that can support durable capacity utilization and margin recovery. Sustained top-line growth provides a foundation to rebuild profitability and cash generation if cost structure and pricing are managed.
Read all positive factors

Green Future Food Hydrocolloid Marine Science Co., Ltd. (1084) vs. iShares MSCI Hong Kong ETF (EWH)

Green Future Food Hydrocolloid Marine Science Co., Ltd. Business Overview & Revenue Model

Company Description
Green Future Food Hydrocolloid Marine Science Co., Ltd. is a pioneering company specializing in the production and distribution of hydrocolloids derived from marine resources. Operating within the food technology sector, the company focuses on dev...

Green Future Food Hydrocolloid Marine Science Co., Ltd. Financial Statement Overview

Summary
Despite a strong 2025 revenue rebound (+21.3% YoY), profitability and cash conversion weakened sharply: net margin fell to ~0.7% (from ~6.3%) with net income dropping to ~6.4m from ~66.2m, and operating/free cash flow turned negative (~-20.3m / ~-45.4m). Leverage is manageable (debt-to-equity ~0.71), but very low ROE (~0.8%) signals weak returns on the balance sheet.
Income Statement
46
Neutral
Balance Sheet
56
Neutral
Cash Flow
28
Negative
BreakdownTTMDec 2025Dec 2024Dec 2023Dec 2022Dec 2021
Income Statement
Total Revenue726.43M881.28M1.05B1.17B1.64B1.16B
Gross Profit130.85M162.90M236.71M41.90M447.48M270.43M
EBITDA64.54M74.90M163.93M-28.75M390.21M211.36M
Net Income7.72M6.42M66.15M-85.33M199.23M103.62M
Balance Sheet
Total Assets1.70B1.63B1.67B1.54B1.89B1.70B
Cash, Cash Equivalents and Short-Term Investments89.10M108.40M128.47M84.10M43.50M139.36M
Total Debt603.28M593.10M601.33M601.97M649.27M624.50M
Total Liabilities795.02M785.53M768.39M789.49M938.99M837.68M
Stockholders Equity898.69M839.05M893.68M745.24M945.20M841.98M
Cash Flow
Free Cash Flow28.51M-45.42M66.83M84.75M-82.78M-16.41M
Operating Cash Flow60.21M-20.34M116.95M96.52M-32.19M61.11M
Investing Cash Flow-32.38M-25.00M-46.59M-8.13M-51.60M-137.17M
Financing Cash Flow-41.04M14.13M-39.93M-20.55M-5.01M99.46M

Green Future Food Hydrocolloid Marine Science Co., Ltd. Technical Analysis

Technical Analysis Sentiment
Positive
Last Price0.62
Price Trends
50DMA
0.66
Positive
100DMA
0.64
Positive
200DMA
0.66
Positive
Market Momentum
MACD
<0.01
Positive
RSI
50.63
Neutral
STOCH
60.00
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HK:1084, the sentiment is Positive. The current price of 0.62 is below the 20-day moving average (MA) of 0.68, below the 50-day MA of 0.66, and below the 200-day MA of 0.66, indicating a neutral trend. The MACD of <0.01 indicates Positive momentum. The RSI at 50.63 is Neutral, neither overbought nor oversold. The STOCH value of 60.00 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for HK:1084.

Green Future Food Hydrocolloid Marine Science Co., Ltd. Peers Comparison

Overall Rating
UnderperformOutperform
Sector (62)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
71
Outperform
HK$382.32M20.466.47%11.61%20.33%
62
Neutral
$20.33B14.63-3.31%3.23%1.93%-12.26%
52
Neutral
HK$60.67M-0.42-35.24%-20.68%28.62%
45
Neutral
HK$166.50M-3.41-28.40%10.64%-41.81%-645.06%
44
Neutral
HK$52.40M-1.04-10.06%-11.32%-0.51%
43
Neutral
HK$560.22M88.790.88%1.88%-8.45%-89.34%
* Consumer Defensive Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
HK:1084
Green Future Food Hydrocolloid Marine Science Co., Ltd.
0.65
-0.04
-5.80%
HK:0682
Chaoda Modern Agriculture Holdings
0.27
0.03
10.42%
HK:0197
Heng Tai Consumables Group
0.29
0.14
93.33%
HK:1936
Ritamix Global Limited
0.81
0.22
37.29%
HK:6911
Pu'er Lancang Ancient Tea Co., Ltd.
3.00
-0.05
-1.64%

Green Future Food Hydrocolloid Marine Science Co., Ltd. Corporate Events

Green Fresh Biotechnology Sets June 2026 AGM to Approve Dividend, Board Mandates and Share Buyback
Apr 24, 2026
Green Fresh Biotechnology Company Limited has convened its annual general meeting for 12 June 2026 in Hong Kong, where shareholders will review the audited consolidated financial statements and directors&#8217; and auditor&#8217;s reports for the ...
Green Fresh Biotechnology Profit Slumps as Revenue and Margins Decline in 2025
Mar 30, 2026
Green Fresh Biotechnology reported a challenging 2025 financial year, with revenue falling 8.6% to RMB904.7 million and gross profit down to RMB167.2 million, as gross margin compressed from 22.5% to 18.5%. Net profit dropped sharply to RMB5.4 mil...
Green Fresh Biotechnology Declares Final Dividend for 2025
Mar 30, 2026
Green Fresh Biotechnology Company Limited has proposed a final ordinary cash dividend of HKD 0.012 per share for the financial year ended 31 December 2025, reinforcing its practice of distributing profits to shareholders. The dividend, subject to ...
Green Fresh Biotechnology Sets March Board Meeting on 2025 Results and Dividend
Mar 17, 2026
Green Fresh Biotechnology Company Limited has scheduled a board meeting for 30 March 2026 to review and approve the group&#8217;s annual results for the financial year ended 31 December 2025. The board will also consider whether to recommend the p...
Green Fresh warns of steep profit drop on weaker hydrocolloid prices and volumes
Mar 6, 2026
Green Fresh Biotechnology has warned investors that its net profit attributable to shareholders for the year ended 31 December 2025 is expected to fall sharply to not more than RMB8 million, from about RMB62.2 million a year earlier. The company a...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Apr 29, 2026